Eli Lilly
LLY
#13
Rank
S$1.174 T
Marketcap
S$1,310
Share price
-0.41%
Change (1 day)
19.23%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

EPS for Eli Lilly (LLY)

EPS in 2025 (TTM): S$26.85

According to Eli Lilly's latest financial reports the company's current EPS (TTM) is S$26.60. In 2024 the company made an earnings per share (EPS) of S$15.27 an increase over its 2023 EPS that were of S$7.32.

EPS history for Eli Lilly from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$26.8575.86%
2024S$15.27108.52%
2023S$7.32-15.84%
2022S$8.7013.5%
2021S$7.67-8.67%
2020S$8.39-24.47%
2019S$11.11176.13%
2018S$4.02-1283.82%
2017S-$0.34-110.57%
2016S$3.2214.25%
2015S$2.821.55%
2014S$2.77-48.58%
2013S$5.3914.25%
2012S$4.72-6.63%
2011S$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
S$3.85-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.53-49.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.80-81.94%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$4.66-82.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
S$1.75-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.89-36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.54-64.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
S$3.93-85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK